I doubt Cramer is aware of the Rules 24/60 motions pending in Nevada, the petition for cert before the S.Ct., or anything else concerning Amarin, including the progress of Vascepa in Europe/China or even KM, the new CEO effective 8/1/2021.
I suggest someone put a package of links together and send the package to Cramer via email to educate that one-time lawyer about Amarin. Remind him that further events have occurred since he last opined that Amarin is a “good speculation”—he just might correct/dial back his opinion uttered yesterday should he be apprised of what is really going on, other than what his quick glance at a chart seems to portray.